BWAY
Price
$11.72
Change
-$0.12 (-1.01%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
86.77M
12 days until earnings call
VREX
Price
$7.85
Change
+$0.30 (+3.97%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
732.76M
13 days until earnings call
Interact to see
Advertisement

BWAY vs VREX

Header iconBWAY vs VREX Comparison
Open Charts BWAY vs VREXBanner chart's image
BrainsWay
Price$11.72
Change-$0.12 (-1.01%)
Volume$1K
Capitalization86.77M
Varex Imaging
Price$7.85
Change+$0.30 (+3.97%)
Volume$1.56K
Capitalization732.76M
BWAY vs VREX Comparison Chart in %
Loading...
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VREX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BWAY vs. VREX commentary
Jul 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BWAY is a Hold and VREX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2025
Stock price -- (BWAY: $11.84 vs. VREX: $7.55)
Brand notoriety: BWAY and VREX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BWAY: 23% vs. VREX: 71%
Market capitalization -- BWAY: $86.77M vs. VREX: $732.76M
BWAY [@Medical Specialties] is valued at $86.77M. VREX’s [@Medical Specialties] market capitalization is $732.76M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BWAY’s FA Score shows that 0 FA rating(s) are green whileVREX’s FA Score has 0 green FA rating(s).

  • BWAY’s FA Score: 0 green, 5 red.
  • VREX’s FA Score: 0 green, 5 red.
According to our system of comparison, BWAY is a better buy in the long-term than VREX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BWAY’s TA Score shows that 4 TA indicator(s) are bullish while VREX’s TA Score has 5 bullish TA indicator(s).

  • BWAY’s TA Score: 4 bullish, 5 bearish.
  • VREX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VREX is a better buy in the short-term than BWAY.

Price Growth

BWAY (@Medical Specialties) experienced а -2.55% price change this week, while VREX (@Medical Specialties) price change was -3.82% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.88%. For the same industry, the average monthly price growth was +5.07%, and the average quarterly price growth was -2.40%.

Reported Earning Dates

BWAY is expected to report earnings on Aug 06, 2025.

VREX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+2.88% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VREX($733M) has a higher market cap than BWAY($86.8M). BWAY YTD gains are higher at: 25.557 vs. VREX (-48.252). VREX has higher annual earnings (EBITDA): 85.6M vs. BWAY (-8.43M). VREX has more cash in the bank: 141M vs. BWAY (44.2M). BWAY has less debt than VREX: BWAY (754K) vs VREX (470M). VREX has higher revenues than BWAY: VREX (878M) vs BWAY (28.8M).
BWAYVREXBWAY / VREX
Capitalization86.8M733M12%
EBITDA-8.43M85.6M-10%
Gain YTD25.557-48.252-53%
P/E RatioN/A18.22-
Revenue28.8M878M3%
Total Cash44.2M141M31%
Total Debt754K470M0%
FUNDAMENTALS RATINGS
BWAY vs VREX: Fundamental Ratings
BWAY
VREX
OUTLOOK RATING
1..100
6820
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
59100
SMR RATING
1..100
7892
PRICE GROWTH RATING
1..100
4287
P/E GROWTH RATING
1..100
10040
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BWAY's Valuation (75) in the Medical Specialties industry is in the same range as VREX (85). This means that BWAY’s stock grew similarly to VREX’s over the last 12 months.

BWAY's Profit vs Risk Rating (59) in the Medical Specialties industry is somewhat better than the same rating for VREX (100). This means that BWAY’s stock grew somewhat faster than VREX’s over the last 12 months.

BWAY's SMR Rating (78) in the Medical Specialties industry is in the same range as VREX (92). This means that BWAY’s stock grew similarly to VREX’s over the last 12 months.

BWAY's Price Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for VREX (87). This means that BWAY’s stock grew somewhat faster than VREX’s over the last 12 months.

VREX's P/E Growth Rating (40) in the Medical Specialties industry is somewhat better than the same rating for BWAY (100). This means that VREX’s stock grew somewhat faster than BWAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BWAYVREX
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 19 days ago
84%
Bullish Trend 3 days ago
64%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 11 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
56%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VREX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LDGYY16.38N/A
N/A
Landis Gyr Group AG
TBVPF0.38N/A
N/A
Thai Beverage Public Co., Ltd.
CAIB0.08N/A
N/A
California International Bank
HAWLI13.64N/A
N/A
Hawaiian Electric Co., Inc.
KCLI30.43-0.11
-0.35%
Kansas City Life Insurance Co.

BWAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BWAY has been loosely correlated with OFIX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BWAY jumps, then OFIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BWAY
1D Price
Change %
BWAY100%
-0.42%
OFIX - BWAY
33%
Loosely correlated
-2.26%
CLPT - BWAY
31%
Poorly correlated
-2.59%
VREX - BWAY
29%
Poorly correlated
-0.40%
BFLY - BWAY
29%
Poorly correlated
-3.26%
BVS - BWAY
29%
Poorly correlated
-1.08%
More

VREX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VREX has been loosely correlated with NVST. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VREX jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VREX
1D Price
Change %
VREX100%
-0.40%
NVST - VREX
51%
Loosely correlated
+3.14%
ATR - VREX
50%
Loosely correlated
+0.38%
GMED - VREX
48%
Loosely correlated
-1.39%
A - VREX
45%
Loosely correlated
+0.74%
IRMD - VREX
44%
Loosely correlated
-0.70%
More